DENTSPLY SIRONA Files 8-K: Reg FD & Financials
Ticker: XRAY · Form: 8-K · Filed: Sep 8, 2025 · CIK: 818479
| Field | Detail |
|---|---|
| Company | Dentsply Sirona Inc. (XRAY) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-disclosure, financials, 8-k
TL;DR
DENTSPLY SIRONA dropped an 8-K on Sept 8th covering Reg FD and financials. Check it out.
AI Summary
DENTSPLY SIRONA Inc. filed an 8-K on September 8, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing pertains to the company's operations as of September 8, 2025, with its principal executive offices located in Charlotte, North Carolina.
Why It Matters
This filing provides important updates on DENTSPLY SIRONA's regulatory disclosures and financial reporting, which are crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K for regulatory and financial disclosures, not indicating any immediate or significant adverse events.
Key Numbers
- 0000818479-25-000167 — Accession Number (Unique identifier for this SEC filing.)
Key Players & Entities
- DENTSPLY SIRONA Inc. (company) — Registrant
- September 8, 2025 (date) — Date of Report
- Charlotte, North Carolina (location) — Principal executive offices
- 3843 (industry_code) — Standard Industrial Classification
- 0000818479-25-000167 (filing_id) — Accession Number
FAQ
What specific event triggered this 8-K filing?
The filing is for a Regulation FD Disclosure and Financial Statements and Exhibits as of September 8, 2025.
What is the primary business of DENTSPLY SIRONA Inc. according to the filing?
The company is in the DENTAL EQUIPMENT & SUPPLIES industry, with SIC code 3843.
Where are DENTSPLY SIRONA Inc.'s principal executive offices located?
The principal executive offices are located at 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607.
What is the fiscal year end for DENTSPLY SIRONA Inc.?
The fiscal year end is December 31 (1231).
What is the telephone number provided for DENTSPLY SIRONA Inc.?
The registrant's telephone number is (844) 848-0137.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-09-08 08:33:06
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market
Filing Documents
- xray-20250908.htm (8-K) — 26KB
- wellspectstrategicaltern.htm (EX-99.1) — 7KB
- wellspectstrategicaltern001.jpg (GRAPHIC) — 238KB
- wellspectstrategicaltern002.jpg (GRAPHIC) — 210KB
- 0000818479-25-000167.txt ( ) — 770KB
- xray-20250908.xsd (EX-101.SCH) — 2KB
- xray-20250908_lab.xml (EX-101.LAB) — 22KB
- xray-20250908_pre.xml (EX-101.PRE) — 13KB
- xray-20250908_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On September 8, 2025, DENTSPLY SIRONA Inc. (the "Company") issued a press release announcing that it has completed its previously disclosed process to evaluate strategic alternatives for its Wellspect Healthcare business ("Wellspect") and the Company's Board of Directors has determined that Wellspect will continue to operate within the Company's portfolio. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits: Exhibit No. Description 99.1 DENTSPLY SIRONA Inc. Press release issued September 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DENTSPLY SIRONA Inc. By: /s/ Richard C. Rosenzweig Richard C. Rosenzweig Executive Vice President, Corporate Development, General Counsel and Secretary Date: September 8, 2025